DIVERSITY, EQUITY, & INCLUSION

Connecting the Dots

Designing inclusive clinical trials, conducting site feasibility, and connecting patients with relevant trials is a challenge — one TriNetX is committed to helping solve. See how TriNetX plays a pivotal role in bringing life science companies and healthcare organizations together for better patient outcomes.

Diversity by Design: Ensuring More Inclusive Studies with TriNetX Real-World Data

Having representative patient populations in your trial designs is crucial to understanding disease and designing successful clinical trials. Evaluating patient eligibility criteria and its impact on enrollment helps us anticipate and adjust these criteria when it’s most crucial: before your study even begins.

Stream our webinar to hear from Beth Brooks, Head of Patient Insights and Behavioral Sciences at Sanofi, who will share how utilizing TriNetX has improved her team’s research outcomes from protocol to results. We will also be joined by a member of our TriNetX Clinical Feasibility & Analytics team to share best practices when querying diverse patient populations.

Addressing Research Challenges with Diversity and Inclusion

Diversity is a moral and scientific issue in clinical research. Hear members of the TriNetX community from Novartis, Sanofi, PPD, and Boston Medical Center discuss the importance and efforts undertaken to reduce bias, promote social equity and empowerment, and produce innovative science informed by a representative population of patients that will ultimately receive treatment.